With 2 mL, the same 0.1 mL is only a 5% loss
The addition of AMPLITUDE-O data refined evidence for cardiovascular benefits, in particular showing reduction in hospital admission for heart failure, and suggested exendin-4-based compounds lower risks as well as human-based GLP-1 receptor agonists, Naveed Sattar, MD, PhD, professor of metabolic medicine at the University of Glasgow in the U.K., and colleagues wrote
CNG DNG: Lm m np nhn, h tr nng c v tng n hi tc th, thc y ti to ln da cng mng tr trung, ngn nga lo ha hiu qu vi Kojyl Dipeptide-23
Kim SK, Park KY, Choe JY
Retatrutide targets three key hormone receptors GLP-1, GIP, and glucagon making it a unique multi-receptor agonist